Chemotherapy, Osimertinib, Mcla-129
Colorectal Cancer, Gastric Cancer, Head And Neck Squamous Cell Carcinoma, Esophageal Squamous Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic
Recruiting
Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in Combination
―